LOS ANGELES (Legal Newsline) – A California consumer alleges she purchased a dietary supplement that contains an ingredient that is banned for commercial sale for human consumption in the U.S.
Doris Chaney, individually and on behalf of all others similarly situated, filed a complaint on Sept. 19 in the U.S. District Court for the Central District of California against Absorb Health LLC over alleged violation of California Consumer Legal Remedies Act, False Advertising Law and California's Unfair Competition Law.
According to the complaint, the defendant's dietary supplement Aniracetam contain racetams, which are banned for commercial sale for human consumption in the U.S. The plaintiff alleges she purchased the product in March from the defendant's website.
The suit states the product is advertised as a dietary supplement capable of “improv[ing] memory and learning” and can “decrease anxiety and depression.”
The plaintiff holds Absorb Health LLC responsible because the defendant allegedly misrepresented the nature and capabilities of the product in order to induce consumers to purchase the products.
The plaintiff requests a trial by jury and seeks judgment for general and compensatory damages, award of prejudgment interest and other relief the court may deem just and proper. She is represented by Abbas Kazerounian and Mona Amini of Kazerouni Law Group APC in Costa Mesa, California.
U.S. District Court for the Central District of California case number 2:18-cv-08121-RGK-SK